NCT03382223 · ACTIVE NOT RECRUITING

Panel Study Investigating Status of Cognitively Impaired Elderly in Singapore

This is an observational study in Singapore, not a clinical trial testing a drug or therapy. Researchers are surveying caregivers of people with severe dementia every few months until the patient dies, and then during bereavement. The goal is to better understand end-of-life care, costs, and caregiver burden, and to build a tool that predicts six-month mortality. No phase is listed because no intervention is being tested.

Eligibility criteria

Inclusion Criteria for primary informal caregivers are:
1. Age ≥ 21 years old
2. Singaporean/Singapore Permanent Resident
3. Intact cognition determined through the Abbreviated Mental Test (AMT) for those who are ≥ 65 years old
4. Patients who score 20 or more on QDRS answered by caregivers will be considered to have severe dementia
5. Main person or one of the main persons providing care to patient (e.g. accompanying patient for doctor's visits, helping patient with day to day activities)
6. Main person or one of the main persons ensuring the provision of care to patient (e.g. supervision of foreign domestic worker so that patient is looked after)
7. Main person or one of the main persons involved in making decisions regarding treatment patient receives
Exclusion Criteria for primary informal caregivers are:
1. Caregivers ≥ 65 years old with cognitive impairment or serious mental illness determined through AMT
2. Foreign domestic workers/maids
Inclusion Criteria for physicians are:
(a) Caregivers of patients they are treating are enrolled in the study

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-04-17

View full record on ClinicalTrials.gov

All APOE4 clinical trials